VION Biosciences
Mark Thornton currently serves as the Chief Executive Officer of VION Biosciences, a life science company focused on manufacturing critical materials and enabling scientific advancements. Additionally, Mark serves as a Board Member at Nova Molecular Technologies, Inc., and provides executive advisory services at Iron Path Capital. Previously, Mark held senior leadership roles at VWR, overseeing sales application specialists and strategic portfolio management for chemicals and life sciences. Mark's earlier experience includes directorial roles at Amresco and research positions at Cleveland Clinic and Athersys, contributing to significant scientific projects. Mark holds an MBA in Marketing and a BS in Biology from Cleveland State University.
This person is not in any teams
This person is not in any offices
VION Biosciences
VION Biosciences is a best-in-class life science platform delivering market-leading manufacturing and mission-critical chemicals and specialty reagents alongside value-added services to enable scientific discovery, clinical testing, therapeutic development, and innovative solutions across a wide platform of key applications in the biochemical and life science sectors, from research to commercialization.